Nucleai vs Pomicell
Nucleai vs Pomicell, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nucleai is on 63/100 and Pomicell on 46/100.
Where each one leads
Nucleai
- our overall score: 63/100 against 46/100
- agent readiness: 42/100 against 21/100
- domain rating: 29/100 against 4/100
- headcount: 66 against 5
- headcount growth: -7.0% against -29.7%
- funding raised: $58.5M against $300K
- LinkedIn following: 18,902 against 2,777
Pomicell
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Nucleai | Pomicell |
|---|---|---|
| What it is | AI-powered spatial biology platform for precision medicine and drug development. | Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights. |
| Category | Healthcare, Oncology, Pharmaceutical, HealthTech | Healthcare, Biotech, Decision Support, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2016 |
| Headquarters | Tel Aviv, Israel | Jerusalem, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Nucleai | Pomicell |
|---|---|---|
| Employees | 66 | 5 |
| Headcount growthLast 12 months | -7.0% | -29.7% |
| Total funding | $58.5M | $300K |
| Latest round | Series B | Seed |
| LinkedIn followers | 18,902 | 2,777 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nucleai | Pomicell |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 46/100 |
| Traction | 57/100 | 35/100 |
| Team | 70/100 | 50/100 |
| Community | 8/100 | Not published |
| Search visibility | 31/100 | 36/100 |
| Quality | 68/100 | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nucleai | Pomicell |
|---|---|---|
| CMS | WordPress | Wix |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager, Linkedin Insight, Facebook Pixel | Not detected |
| Support stack | HubSpot | Not detected |
Nucleai vs Pomicell: common questions
Which is better, Nucleai or Pomicell?
On our 0-100 score Nucleai rates higher (63/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Nucleai and Pomicell compare on the numbers?
Nucleai leads on our overall score (63/100 against 46/100), agent readiness (42/100 against 21/100), domain rating (29/100 against 4/100), headcount (66 against 5), headcount growth (-7.0% against -29.7%), funding raised ($58.5M against $300K), LinkedIn following (18,902 against 2,777).
Read the full Nucleai review and pricing or the Pomicell review and pricing. You can also browse other Nucleai alternatives we track.